Orchid Pharma Ltd
NSE:ORCHPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
IN |
|
A
|
ASMPT Ltd
SWB:AY7A
|
HK |
|
S
|
Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
|
CN |
|
Mapletree Industrial Trust
SGX:ME8U
|
SG |
|
I
|
Iyo Bank Ltd
TSE:8385
|
JP |
|
Tway Holdings Inc
KRX:004870
|
KR |
|
L
|
Lysaght Galvanized Steel Bhd
KLSE:LYSAGHT
|
MY |
|
SoftSol India Ltd
BSE:532344
|
IN |
|
R1 RCM Holdco Inc
F:6HL0
|
US |
|
AK Medical Holdings Ltd
HKEX:1789
|
CN |
|
M
|
M N C Wireless Bhd
KLSE:MNC
|
MY |
|
Juki Corp
TSE:6440
|
JP |
|
E
|
Exosens SAS
PAR:EXENS
|
FR |
|
V
|
VIP Gloves Ltd
ASX:VIP
|
MY |
|
Jeronimo Martins SGPS SA
OTC:JRONY
|
PT |
|
K
|
Kayne Anderson BDC Inc
NYSE:KBDC
|
US |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
NYSE:SBS
|
BR |
|
G
|
Generix Group SA
LSE:0JAW
|
FR |
Wall Street
Price Targets
ORCHPHARMA Price Targets Summary
Orchid Pharma Ltd
According to Wall Street analysts, the average 1-year price target for
ORCHPHARMA
is 970.53 INR
with a low forecast of 909 INR and a high forecast of 1 053.15 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ORCHPHARMA's stock price target?
Price Target
970.53
INR
According to Wall Street analysts, the average 1-year price target for
ORCHPHARMA
is 970.53 INR
with a low forecast of 909 INR and a high forecast of 1 053.15 INR.
What is Orchid Pharma Ltd's Revenue forecast?
Projected CAGR
31%
For the last 13 years the
compound annual growth rate for
Orchid Pharma Ltd's revenue is
-5%.
The projected
CAGR
for the next 3 years is
31%.
What is Orchid Pharma Ltd's Operating Income forecast?
Projected CAGR
58%
For the last 13 years the
compound annual growth rate for
Orchid Pharma Ltd's operating income is
-9%.
The projected
CAGR
for the next 3 years is
58%.
What is Orchid Pharma Ltd's Net Income forecast?
Projected CAGR
28%
For the last 13 years the
compound annual growth rate for
Orchid Pharma Ltd's net income is
0%.
The projected
CAGR
for the next 3 years is
28%.
